{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T16:07:04Z","timestamp":1775146024086,"version":"3.50.1"},"reference-count":73,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"vor","delay-in-days":731,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100001003","name":"BIPI","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100001003","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","resmedjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.rmed.2019.06.008","type":"journal-article","created":{"date-parts":[[2019,6,12]],"date-time":"2019-06-12T00:12:04Z","timestamp":1560298324000},"page":"47-55","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["Tiotropium in asthma: From bench to bedside"],"prefix":"10.1016","volume":"154","author":[{"given":"Lyndon","family":"Mansfield","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan A.","family":"Bernstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.rmed.2019.06.008_bib1","first-page":"1789","article-title":"Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries, for 195 countries, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017","volume":"392","author":"GBD 2017 Disease and Injury Incidence and Prevalence Collaborators","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.rmed.2019.06.008_bib2","first-page":"1736","article-title":"Global, regional, and national age-specific mortality for 282 causes of death in 195 countries and territories, 1980\u20132017: a systematic analysis for the Global Burden of Disease Study 2017","volume":"392","author":"GBD 2017 Causes of Death Collaborators","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.rmed.2019.06.008_bib3","series-title":"Expert Panel Report 3: Guidelines for the Diagnosis and Management of Asthma","first-page":"1","author":"Busse","year":"2007"},{"key":"10.1016\/j.rmed.2019.06.008_bib4","series-title":"Global Strategy for Asthma Management and Prevention, 2018 [Internet]. Global Initiative for Asthma","author":"Global Initiative for Asthma","year":"2018"},{"key":"10.1016\/j.rmed.2019.06.008_bib5","unstructured":"Food and Drug Administration. Application number 21-395 Approval letter(s) 2004 [Internet]. [cited 2016 August 5]. Available from: http:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2004\/21-395.pdf_Spiriva_Approv.pdf."},{"issue":"2\u20133","key":"10.1016\/j.rmed.2019.06.008_bib6","first-page":"219","article-title":"Systematic review of clinical outcomes in chronic obstructive pulmonary disease: beta-agonist use compared with anticholinergics and inhaled corticosteroids","volume":"31","author":"Salpeter","year":"2006","journal-title":"Clin. Rev. Allergy Immunol."},{"issue":"2 Suppl","key":"10.1016\/j.rmed.2019.06.008_bib7","first-page":"125S","article-title":"Therapeutic responses in asthma and COPD","volume":"126","author":"Donohue","year":"2004","journal-title":"Bronchodilators. Chest."},{"issue":"1","key":"10.1016\/j.rmed.2019.06.008_bib8","first-page":"60","article-title":"Anticholinergic agents in asthma: chronic bronchodilator therapy, relief of acute severe asthma, reduction of chronic viral inflammation and prevention of airway remodeling","volume":"12","author":"Kanazawa","year":"2006","journal-title":"Curr. Opin. Pulm. Med."},{"key":"10.1016\/j.rmed.2019.06.008_bib9","series-title":"NDA Approval Spiriva Respimat Ref ID 3819832 2015 [Internet]. Silver Spring (MD)","author":"Food and Drug Administration","year":"2015"},{"key":"10.1016\/j.rmed.2019.06.008_bib10","series-title":"FDA Expands Approval of SPIRIVA\u00ae RESPIMAT\u00ae (Tiotropium Bromide) Inhalation Spray for Maintenance Treatment of Asthma in Children","year":"2017"},{"issue":"7 SUPPL","key":"10.1016\/j.rmed.2019.06.008_bib11","first-page":"13","article-title":"Historical review of the use of parasympatholytic agents in the treatment of respiratory disorders","volume":"51","author":"Gandevia","year":"1974","journal-title":"Postgrad. Med. J."},{"issue":"12","key":"10.1016\/j.rmed.2019.06.008_bib12","first-page":"1002","article-title":"Pharmacological properties of Datura stramonium L. as a potential medicinal tree: an overview","volume":"2","author":"Soni","year":"2012","journal-title":"Asian. Pac. J. Trop. Biomed."},{"issue":"2","key":"10.1016\/j.rmed.2019.06.008_bib13","first-page":"171","article-title":"\u201cDivine Stramonium\u201d: the rise and fall of smoking for asthma","volume":"54","author":"Jackson","year":"2010","journal-title":"Med. Hist."},{"issue":"1","key":"10.1016\/j.rmed.2019.06.008_bib14","first-page":"44","article-title":"Muscarinic receptor antagonists, from folklore to pharmacology; finding drugs that actually work in asthma and COPD","volume":"163","author":"Moulton","year":"2011","journal-title":"Br. J. Pharmacol."},{"issue":"7","key":"10.1016\/j.rmed.2019.06.008_bib15","first-page":"833","article-title":"Use of inhaled anticholinergic agents in obstructive airway disease","volume":"52","author":"Restrepo","year":"2007","journal-title":"Respir. Care"},{"issue":"8","key":"10.1016\/j.rmed.2019.06.008_bib16","first-page":"486","article-title":"Ipratropium bromide","volume":"319","author":"Gross","year":"1988","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.rmed.2019.06.008_bib17","first-page":"CD003269","article-title":"Anticholinergic agents for chronic asthma in adults","volume":"3","author":"Westby","year":"2004","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.rmed.2019.06.008_bib18","series-title":"Pocket Guide for Asthma Management and Prevention 2015","author":"Global Initiative for Asthma","year":"2015"},{"issue":"5","key":"10.1016\/j.rmed.2019.06.008_bib19","first-page":"899","article-title":"Characterization of [3H]Ba 679 BR, a slowly dissociating muscarinic antagonist, in human lung: radioligand binding and autoradiographic mapping","volume":"45","author":"Haddad","year":"1994","journal-title":"Mol. Pharmacol."},{"issue":"2","key":"10.1016\/j.rmed.2019.06.008_bib20","first-page":"183","article-title":"Tiotropium: an inhaled, long-acting anticholinergic drug for chronic obstructive pulmonary disease","volume":"23","author":"Panning","year":"2003","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.rmed.2019.06.008_bib21","first-page":"73","article-title":"Muscarinic receptor signaling in the pathophysiology of asthma and COPD","volume":"7","author":"Gosens","year":"2006","journal-title":"Respir. Res."},{"key":"10.1016\/j.rmed.2019.06.008_bib22","first-page":"48","article-title":"Role of parasympathetic nerves and muscarinic receptors in allergy and asthma","volume":"98","author":"Scott","year":"2012","journal-title":"Chem. Immunol. Allergy"},{"issue":"5","key":"10.1016\/j.rmed.2019.06.008_bib23","first-page":"2498","article-title":"Acetylcholine is an autocrine or paracrine hormone synthesized and secreted by airway bronchial epithelial cells","volume":"145","author":"Proskocil","year":"2004","journal-title":"Endocrinology"},{"issue":"7","key":"10.1016\/j.rmed.2019.06.008_bib24","first-page":"421","article-title":"Role of the parasympathetic system in airway obstruction due to emphysema","volume":"311","author":"Gross","year":"1984","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.rmed.2019.06.008_bib25","first-page":"47","article-title":"Muscarinic M3 receptors mediate contraction of human central and peripheral airway smooth muscle","volume":"3","author":"Roffel","year":"1990","journal-title":"Pulm. Pharmacol."},{"issue":"4","key":"10.1016\/j.rmed.2019.06.008_bib26","first-page":"765","article-title":"A short tour around the muscarinic receptor","volume":"138","author":"Gross","year":"1988","journal-title":"Am. Rev. Respir. Dis."},{"issue":"2_suppl","key":"10.1016\/j.rmed.2019.06.008_bib27","first-page":"63S","article-title":"The pharmacological properties of tiotropium","volume":"117","author":"Barnes","year":"2000","journal-title":"Chest"},{"issue":"6\u20137","key":"10.1016\/j.rmed.2019.06.008_bib28","first-page":"457","article-title":"Tiotropium (Spiriva): mechanistical considerations and clinical profile in obstructive lung disease","volume":"64","author":"Disse","year":"1999","journal-title":"Life Sci."},{"issue":"8637","key":"10.1016\/j.rmed.2019.06.008_bib29","first-page":"520","article-title":"Subepithelial fibrosis in the bronchi of asthmatics","volume":"333","author":"Roche","year":"1989","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.rmed.2019.06.008_bib30","first-page":"916","article-title":"Marked goblet cell hyperplasia with mucus accumulation in the airways of patients who died of severe acute asthma attack","volume":"101","author":"Aikawa","year":"1992","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.rmed.2019.06.008_bib31","first-page":"78","article-title":"Early thickening of the reticular basement membrane in children with difficult asthma","volume":"167","author":"Payne","year":"2003","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"1","key":"10.1016\/j.rmed.2019.06.008_bib32","first-page":"380","article-title":"Identification of circulating fibrocytes as precursors of bronchial myofibroblasts in asthma","volume":"171","author":"Schmidt","year":"2003","journal-title":"J. Immunol."},{"issue":"4","key":"10.1016\/j.rmed.2019.06.008_bib33","first-page":"653","article-title":"Inhibition of allergen-induced airway remodelling by tiotropium and budesonide: a comparison","volume":"30","author":"Bos","year":"2007","journal-title":"Eur. Respir. J."},{"issue":"10","key":"10.1016\/j.rmed.2019.06.008_bib34","first-page":"1096","article-title":"Protective effects of tiotropium bromide in the progression of airway smooth muscle remodeling","volume":"171","author":"Gosens","year":"2005","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"1","key":"10.1016\/j.rmed.2019.06.008_bib35","first-page":"44","article-title":"Tiotropium bromide inhibits relapsing allergic asthma in BALB\/c mice","volume":"27","author":"Bosnjak","year":"2014","journal-title":"Pulm. Pharmacol. Therapeut."},{"issue":"1","key":"10.1016\/j.rmed.2019.06.008_bib36","first-page":"3","article-title":"Pathophysiology of asthma","volume":"42","author":"Barnes","year":"1996","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"8","key":"10.1016\/j.rmed.2019.06.008_bib37","first-page":"1266","article-title":"Effect of tiotropium bromide on airway inflammation and remodelling in a mouse model of asthma","volume":"40","author":"Ohta","year":"2010","journal-title":"Clin. Exp. Allergy"},{"issue":"1","key":"10.1016\/j.rmed.2019.06.008_bib38","first-page":"29","article-title":"Effect of tiotropium bromide on airway remodeling in a chronic asthma model","volume":"109","author":"Kang","year":"2012","journal-title":"Ann. Allergy Asthma Immunol."},{"issue":"4 Pt 1","key":"10.1016\/j.rmed.2019.06.008_bib39","first-page":"876","article-title":"Prolonged effect of tiotropium bromide on methacholine-induced bronchoconstriction in asthma","volume":"154","author":"O'Connor","year":"1996","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"6","key":"10.1016\/j.rmed.2019.06.008_bib40","first-page":"259","article-title":"Early protective effects of tiotropium bromide in patients with airways hyperresponsiveness","volume":"8","author":"Terzano","year":"2004","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"issue":"2","key":"10.1016\/j.rmed.2019.06.008_bib41","first-page":"308","article-title":"Tiotropium improves lung function in patients with severe uncontrolled asthma: a randomized controlled trial","volume":"128","author":"Kerstjens","year":"2011","journal-title":"J. Allergy Clin. Immunol."},{"issue":"2","key":"10.1016\/j.rmed.2019.06.008_bib42","first-page":"315","article-title":"Tiotropium is noninferior to salmeterol in maintaining improved lung function in B16-Arg\/Arg patients with asthma","volume":"128","author":"Bateman","year":"2011","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.rmed.2019.06.008_bib43","first-page":"61","article-title":"Tiotropium Respimat\u00ae in asthma: a double-blind, randomized, dose-ranging study in adult patients with moderate asthma","volume":"15","author":"Beeh","year":"2014","journal-title":"Respir. Res."},{"issue":"3","key":"10.1016\/j.rmed.2019.06.008_bib44","first-page":"329","article-title":"Once-daily tiotropium Respimat\u00ae 5 mug is an efficacious 24-h bronchodilator in adults with symptomatic asthma","volume":"109","author":"Timmer","year":"2015","journal-title":"Respir. Med."},{"issue":"9","key":"10.1016\/j.rmed.2019.06.008_bib45","first-page":"1268","article-title":"Tiotropium in asthmatic adolescents symptomatic despite inhaled corticosteroids: a randomized dose-ranging study","volume":"108","author":"Vogelberg","year":"2014","journal-title":"Respir. Med."},{"key":"10.1016\/j.rmed.2019.06.008_bib46","first-page":"20","article-title":"A randomised dose-ranging study of tiotropium Respimat\u00ae in children with symptomatic asthma despite inhaled corticosteroids","volume":"16","author":"Vogelberg","year":"2015","journal-title":"Respir. Res."},{"issue":"18","key":"10.1016\/j.rmed.2019.06.008_bib48","first-page":"1715","article-title":"Tiotropium bromide step-up therapy for adults with uncontrolled asthma","volume":"363","author":"Peters","year":"2010","journal-title":"N. Engl. J. Med."},{"issue":"13","key":"10.1016\/j.rmed.2019.06.008_bib49","first-page":"1198","article-title":"Tiotropium in asthma poorly controlled with standard combination therapy","volume":"367","author":"Kerstjens","year":"2012","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.rmed.2019.06.008_bib50","first-page":"367","article-title":"Tiotropium or salmeterol as add-on therapy to inhaled corticosteroids for patients with moderate symptomatic asthma: two replicate, double-blind, placebo-controlled, parallel-group, active-comparator, randomised trials","volume":"3","author":"Kerstjens","year":"2015","journal-title":"Lancet Respir Med"},{"issue":"1","key":"10.1016\/j.rmed.2019.06.008_bib51","first-page":"104","article-title":"The effect of tiotropium in symptomatic asthma despite low- to medium-dose inhaled corticosteroids: a randomized controlled trial","volume":"4","author":"Paggiaro","year":"2016","journal-title":"J. Allergy Clin. Immunol. Pract."},{"issue":"4","key":"10.1016\/j.rmed.2019.06.008_bib52","article-title":"Long-rerm once-daily tiotropium Respimat\u00ae is well tolerated and maintains efficacy over 52 weeks in patients with symptomatic asthma in Japan: a randomized, placebo-controlled study","volume":"10","author":"Ohta","year":"2015","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.rmed.2019.06.008_bib53","first-page":"441","article-title":"Tiotropium add-on therapy in adolescents with moderate asthma: a 1-year randomized controlled trial","volume":"138","author":"Hamelmann","year":"2016","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.rmed.2019.06.008_bib54","article-title":"A randomized controlled trial of tiotropium in adolescents with severe symptomatic asthma","author":"Hamelmann","year":"2016","journal-title":"Eur. Respir. J."},{"issue":"5","key":"10.1016\/j.rmed.2019.06.008_bib55","first-page":"1277","article-title":"A phase III randomized controlled trial of tiotropium add-on therapy in children with severe symptomatic asthma","volume":"140","author":"Szefler","year":"2017","journal-title":"J. Allergy Clin. Immunol."},{"issue":"6","key":"10.1016\/j.rmed.2019.06.008_bib56","first-page":"2160","article-title":"Tiotropium add-on therapy improves lung function in children with symptomatic moderate asthma","volume":"6","author":"Vogelberg","year":"2018","journal-title":"J. Allergy Clin. Immunol. Pract."},{"issue":"2","key":"10.1016\/j.rmed.2019.06.008_bib57","first-page":"462","article-title":"Clinical efficacy of tiotropium in children with asthma","volume":"32","author":"Huang","year":"2016","journal-title":"Pak. J. Med. Sci."},{"issue":"2","key":"10.1016\/j.rmed.2019.06.008_bib58","first-page":"127","article-title":"Safety and efficacy of tiotropium in children aged 1\u20135 years with persistent asthmatic symptoms: a randomized, double-blind, placebo-controlled trial","volume":"6","author":"Vrijlandt","year":"2018","journal-title":"Lancet Resp. Med."},{"issue":"9","key":"10.1016\/j.rmed.2019.06.008_bib59","first-page":"941","article-title":"Systemic adverse effects of inhaled corticosteroid therapy: a systematic review and meta-analysis","volume":"159","author":"Lipworth","year":"1999","journal-title":"Arch. Intern. Med."},{"issue":"6","key":"10.1016\/j.rmed.2019.06.008_bib60","first-page":"1218","article-title":"A proof of concept study to evaluate stepping down the dose of fluticasone in combination with salmeterol and tiotropium in severe persistent asthma","volume":"101","author":"Fardon","year":"2007","journal-title":"Respir. Med."},{"issue":"3","key":"10.1016\/j.rmed.2019.06.008_bib61","first-page":"99","article-title":"The efficacy of tiotropium as a steroid-sparing agent in severe asthma","volume":"16","author":"Kapoor","year":"2009","journal-title":"Can. Respir. J."},{"key":"10.1016\/j.rmed.2019.06.008_bib62","first-page":"145","article-title":"Development of Respimat\u00ae soft Mist\u2122 inhaler and its clinical utility in respiratory disorders","volume":"4","author":"Dalby","year":"2011","journal-title":"Med. Devices (Auckl)"},{"issue":"16","key":"10.1016\/j.rmed.2019.06.008_bib63","first-page":"1491","article-title":"Tiotropium Respimat inhaler and the risk of death in COPD","volume":"369","author":"Wise","year":"2013","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.rmed.2019.06.008_bib64","first-page":"53","article-title":"Respimat\u00ae Soft Mist\u2122 inhaler versus hydrofluoroalkane metered dose inhaler","volume":"4","author":"Sch\u00fcrmann","year":"2005","journal-title":"Treat. Respir. Med."},{"key":"10.1016\/j.rmed.2019.06.008_bib65","first-page":"225","article-title":"Asthma patients prefer respimat\u00ae soft Mist\u2122 inhaler to Turbuhaler\u00ae","volume":"4","author":"Hodder","year":"2009","journal-title":"Int. J. Chronic Obstr. Pulm. Dis."},{"issue":"4","key":"10.1016\/j.rmed.2019.06.008_bib66","first-page":"421","article-title":"Tiotropium may improve asthma symptoms and lung function in asthmatic patients with irreversible airway obstruction: the real-life data","volume":"10","author":"Abadoglu","year":"2016","journal-title":"Clin. Res. J."},{"key":"10.1016\/j.rmed.2019.06.008_bib67","first-page":"1","article-title":"Long-acting muscarinic antagonist use in adults with asthma: real-life prescribing and outcomes of add-on therapy with tiotropium bromide","volume":"8","author":"Price","year":"2015","journal-title":"J. Asthma Allergy"},{"issue":"14","key":"10.1016\/j.rmed.2019.06.008_bib68","first-page":"1393","article-title":"Tiotropium use in pediatric patients with asthma or chronic cough","volume":"53","author":"Cook","year":"2014","journal-title":"Clin. Pediatr."},{"issue":"1","key":"10.1016\/j.rmed.2019.06.008_bib69","first-page":"145","article-title":"Costs of asthma in the United States: 2002-2007","volume":"127","author":"Barnett","year":"2011","journal-title":"J. Allergy Clin. Immunol."},{"issue":"7","key":"10.1016\/j.rmed.2019.06.008_bib70","first-page":"A501","article-title":"Cost-effectiveness of tiotropium in the treatment of patients with asthma","volume":"18","author":"Echave","year":"2015","journal-title":"Value Health"},{"issue":"7","key":"10.1016\/j.rmed.2019.06.008_bib71","first-page":"A502","article-title":"Economic evaluation of tiotropium for severe persistent asthma in Portugal","volume":"18","author":"Silva Miguel","year":"2015","journal-title":"Value Health"},{"issue":"7","key":"10.1016\/j.rmed.2019.06.008_bib72","first-page":"A502","article-title":"Economic evaluation of tiotropium administrated through the respimat inhaler as add-on therapy in patients with uncontrolled severe asthma in Poland","volume":"18","author":"Pawlik","year":"2015","journal-title":"Value Health"},{"issue":"1","key":"10.1016\/j.rmed.2019.06.008_bib73","first-page":"119","article-title":"Erratum to: cost effectiveness of tiotropium in patients with asthma poorly controlled on inhaled glucocorticosteroids and long-acting \u03b2-agonists","volume":"14","author":"Willson","year":"2016","journal-title":"Appl. Health Econ. Health Policy"},{"issue":"1","key":"10.1016\/j.rmed.2019.06.008_bib74","article-title":"Cost-effectiveness of tiotropium versus omalizumab for uncontrolled allergic asthma in US","volume":"16","author":"Zafari","year":"2018","journal-title":"Cost Eff. Resour. Allocation"}],"container-title":["Respiratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611119301969?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611119301969?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T11:51:30Z","timestamp":1760615490000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0954611119301969"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":73,"alternative-id":["S0954611119301969"],"URL":"https:\/\/doi.org\/10.1016\/j.rmed.2019.06.008","relation":{},"ISSN":["0954-6111"],"issn-type":[{"value":"0954-6111","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tiotropium in asthma: From bench to bedside","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmed.2019.06.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}